Lanthanum
- TRADE NAME: Fosrenol (Shire)
- INDICATIONS: Hyperphosphatemia in end-stage renal disease
- CLASS: Chelator
- HALF-LIFE: 53 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Chloroquine, Ciprofloxacin, Hydroxychloroquine, Ketoconazole, Levofloxacin, Levothyroxine, Moxifloxacin, Norfloxacin, Ofloxacin, Quinolones
PREGNANCY CATEGORY: C
Contra-indicated in patients with bowel obstruction, ileus, and/or fecal impaction.
Please login to see the rest of this drug profile
SKIN.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric